Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance.

Cancer Letters
Anmbreen JamrozeDean G Tang

Abstract

Androgen receptor (AR), a ligand-dependent nuclear transcription factor and a member of steroid hormone receptor family, plays an important role in prostate organogenesis by regulating epithelial differentiation and restricting cell proliferation. Although rarely mutated or amplified in treatment-naïve prostate cancer (PCa), AR signaling drives tumor growth and as a result, therapies that aim to inhibit AR signaling, called ARSIs (AR signaling inhibitors), have been in clinical use for >70 years. Unfortunately, the clinical efficacy of ARSIs is short-lived and the majority of treated patients develop castration-resistant PCa (CRPC). Numerous molecular mechanisms have been proposed for castration resistance; however, the cellular basis for CRPC emergence has remained obscure. One under-appreciated cellular mechanism for CRPC development is the AR heterogeneity that pre-exists in treatment-naive primary tumors, i.e., although most PCa cells express AR (i.e., AR+), there is always a population of PCa cells that express no/low AR (i.e., AR-/lo). Importantly, this AR heterogeneity becomes accentuated during ARSI treatment and highly prominent in established CRPC. Here, we provide a succinct summary of AR heterogeneity across the PCa...Continue Reading

References

May 10, 1991·International Journal of Cancer. Journal International Du Cancer·T H van der KwastJ Trapman
Jan 1, 1994·Annual Review of Biochemistry·M J Tsai, B W O'Malley
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·I J McEwan, J Gustafsson
Apr 29, 1999·Cell·UNKNOWN Nuclear Receptors Nomenclature Committee
Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·M StanbroughS P Balk
Apr 5, 2002·Molecular Cell·Yongfeng ShangMyles Brown
Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tsutomu NishiyamaKota Takahashi
Jan 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Guangzhou HanNorman M Greenberg
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark A TitusJames L Mohler
Aug 17, 2006·Cancer Research·Zongxiang ZhouAlexander Yu Nikitin
Jul 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·Chun-Te WuChawnshang Chang
Jul 12, 2008·Molecular Endocrinology·Margaret M CenteneraLisa M Butler
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yuanjie NiuChawnshang Chang
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Yuanjie NiuChawnshang Chang
Sep 9, 2010·Proceedings of the National Academy of Sciences of the United States of America·Philip A WatsonCharles L Sawyers
Jan 21, 2011·Nature·Jane E Visvader
Dec 20, 2011·Genome Research·Jonathan C ZhaoJindan Yu
Feb 3, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xinhai WanNora M Navone
May 23, 2012·Nature Genetics·Christopher E BarbieriLevi A Garraway
Dec 11, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hsueh-Li TanTamara L Lotan
Apr 8, 2014·The American Journal of Surgical Pathology·Jonathan I EpsteinMark A Rubin
Jul 23, 2014·Hormones & Cancer·Mary NakazawaJun Luo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.